QualityStocksNewsBreaks Archives - Page 226 of 1582

TuesdayMar 25, 2025 9:00 am

QualityStocksNewsBreaks – Centri Capital Conference to Showcase the Future of Capital Markets

Centri Business Consulting, LLC, one of the industry's fastest-growing and most respected accounting and advisory firms, is set to host its Centri Capital Conference. Slated to take place at Nasdaq in New York City on April 22, the event will bring together key players from the capital markets ecosystem, including investment bankers, private equity investors and venture capitalists. The conference will feature dynamic presentations from companies spanning rapidly growing sectors such as healthcare, life sciences and technology, as well as thought-provoking panel discussions on hot topics including blockchain, AI, IPO trends, and market disruptors. Designed as a platform for networking…

MondayMar 24, 2025 10:45 am

Newton Golf Company (NASDAQ: NWTG) ‘Pioneering New Era’ in Growing Golf Equipment Market

The global golf equipment market is estimated at $18.34 billion in 2024 and forecasted to reach $29.3 billion by 2034. The company’s recent name change “marks a new chapter in our company’s evolution as we push the boundaries of performance in golf equipment,” says CEO. Newton’s advanced physics-driven designs are setting new standards in golf technology, from high-performance shafts to next-generation putters. The global golf equipment market is experiencing significant growth, driven by increasing participation and technological advancements. This upward trend presents substantial opportunities for companies operating within the golf-equipment sector, such as Newton Golf Company (NASDAQ: NWTG), a technology-forward…

MondayMar 24, 2025 9:20 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlights Juve Stabia Academy as Key Youth Football Investment

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on multi-club ownership, spotlighted the Juve Stabia Academy for its role in developing elite football talent in the Naples Metropolitan Area. The investment reflects Brera’s strategy to support grassroots football and create a global network of academies. Juve Stabia has a history of producing top-tier talent, including Luigi Vitale and Antonio Donnarumma, and aligns with Brera’s mission to strengthen football ecosystems and expand pathways for emerging players worldwide. To view the full press release, visit https://ibn.fm/owfgY About Brera Holdings PLC Brera Holdings PLC is focused on expanding its social impact…

FridayMar 21, 2025 2:28 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI): Poised in the Future of Oncology with Cutting-Edge Treatments

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative treatments in the field of immuno-oncology. With cancer being the second leading cause of death globally, the company focuses on harnessing antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. The company’s approach includes a systemic platform using extracellular enveloped viruses and an intratumoral platform utilizing stem cells to protect the therapy from the body’s immune system during administration. Calidi’s pipeline includes promising therapies such as RTNova,…

FridayMar 21, 2025 12:28 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing its lead drug candidate, CNM-Au8®. The company presented its progress at two key investor events this month, including the Q1 Virtual Investor Summit and the 37th Annual Roth Conference. At both events, Clene’s management discussed the latest achievements with CNM-Au8, a gold nanocrystal-based oral suspension that targets mitochondrial dysfunction and promotes neuronal health. The drug has shown promising results in…

FridayMar 21, 2025 11:50 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We remain highly focused on advancing our multiple clinical programs as we work towards achieving a number of important and potentially transformational development milestones, including top-line results in 2026 for our actively enrolling confirmatory Phase 3 placebo-controlled study evaluating HyBryte(TM) (synthetic hypericin) in the treatment of early-stage cutaneous T-cell lymphoma (‘CTCL’),” stated Christopher J. Schaber, PhD, president and chief executive officer…

FridayMar 21, 2025 10:17 am

QualityStocksNewsBreaks – General Mills, Inc. (NYSE: GIS) Reports Mixed Q3 2025 Results, Updates Outlook

General Mills (NYSE: GIS) announced its third-quarter fiscal 2025 results, reporting earnings per share (“EPS”) of $1.00, surpassing analyst expectations of $0.98. However, revenue fell short, totaling $4.8 billion against a projected $4.99 billion. The company attributed the revenue miss to greater-than-expected retailer inventory headwinds and a slowdown in U.S. snacking categories. In response, General Mills plans to invest in consumer value, media support, and in-store visibility in the fourth quarter to drive growth. To view the full article, visit https://ibn.fm/xH2Wq About General Mills General Mills makes food the world loves. The company is guided by its Accelerate strategy to…

ThursdayMar 20, 2025 11:00 am

QualityStocksNewsBreaks – Apple Inc. (NASDAQ: AAPL) Loses Top Health Executive to Oura, Fueling Smart Ring Market Growth

Apple (NASDAQ: AAPL) has lost a key executive from its health division, as Dr. Ricky Bloomfield, formerly the Clinical and Health Informatics Lead, departs to join Oura as its Chief Medical Officer. Bloomfield played a critical role in shaping Apple’s health strategy, including its push into digital health records and wearable health tracking. His move to Oura, a company specializing in smart rings for health monitoring, signals growing competition in the wearable health-tech space, with some analysts seeing it as a potential shift in consumer interest toward ring-based health tracking over smartwatches. As of the latest trading session, Apple’s stock is…

ThursdayMar 20, 2025 10:50 am

QualityStocksNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Faces Proxy Battle as Anson Funds Seeks Board Changes

Match Group (NASDAQ: MTCH), s confronting a proxy challenge from hedge fund Anson Funds, which plans to nominate directors to the company’s 10-member board. Anson, holding approximately 0.6% of Match Group’s shares as of December, has been advocating for over a year for the parent company of Tinder, Hinge, and OkCupid to reassess capital allocation, reduce costs, and evaluate its MG Asia business. The hedge fund has also expressed concerns about corporate governance and executive turnover, noting that Match Group has had four CEOs in five years. As of 10:30 AM EDT on March 20, 2025, Match Group’s stock is…

ThursdayMar 20, 2025 9:35 am

QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Acquires Genetic Networks in $10 Million Stock Deal

Fifty 1 Labs (OTC: FITY) a holding company in the health, wellness, and biotech sectors, has acquired Genetic Networks LLC, a biotech firm founded by Dr. Gennaro D’Urso, for $10 million in common shares. As part of the deal, Dr. D’Urso has been appointed CEO and Chairman, while Brandon Spikes remains President and Director. Genetic Networks, known for its GeneScape™ platform, is actively negotiating multi-million dollar contracts with the U.S. Department of Defense to develop biothreat countermeasures. The acquisition enhances FITY’s biotech capabilities, positioning it for rapid growth in personalized medicine, drug repurposing, and biodefense solutions. To view the full press…

Site Search

Company Search

Category: QualityStocksNewsBreaks